Patent · US Active

Method for removing anti-AAV antibodies from a blood-derived composition

US11376321B2 · kind B2 · utility

0Cited by

2References

17Claims

0Family size

Assignees

GENETHON · FR
INSERM (INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE) · FR
Sorbonne Universite · FR
ASSOCIATION INSTITUT DE MYOLOGIE · FR

Inventors

Bérangére Bertin · Vanves, FR
Carole Masurier · Yerres, FR
Otto-Wilhelm Merten · Crespières, FR
Federico Mingozzi · Paris, FR

Key dates

Filing date	Mar 1, 2018
Grant date	Jul 5, 2022
Priority date	—
Expiry date	Mar 1, 2038

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2750/14141
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to a method for removing undesired anti-AAV antibodies from a blood-derived composition.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.